Quantification of plasma sulfatides by mass spectrometry: Utility for metachromatic leukodystrophy.

[1]  M. Gelb,et al.  Sulfatide Analysis by Mass Spectrometry for Screening of Metachromatic Leukodystrophy in Dried Blood and Urine Samples. , 2016, Clinical chemistry.

[2]  S. Sonnino,et al.  The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane , 2016, Neurochemical Research.

[3]  J. Fletcher,et al.  Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[4]  B. Poorthuis,et al.  Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry[S] , 2015, Journal of Lipid Research.

[5]  C. Krarup,et al.  Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy , 2015, Annals of clinical and translational neurology.

[6]  R. V. van Breemen,et al.  Distribution of C16:0, C18:0, C24:1, and C24:0 sulfatides in central nervous system lipid rafts by quantitative ultra-high-pressure liquid chromatography tandem mass spectrometry. , 2014, Analytical biochemistry.

[7]  D. Mahuran,et al.  Liquid chromatography/electrospray ionisation-tandem mass spectrometry quantification of GM2 gangliosides in human peripheral cells and plasma. , 2014, Analytical biochemistry.

[8]  M. Gelb,et al.  Quantification of sulfatides in dried blood and urine spots from metachromatic leukodystrophy patients by liquid chromatography/electrospray tandem mass spectrometry. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[9]  S. Song,et al.  Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy. , 2014, Rapid communications in mass spectrometry : RCM.

[10]  F. Tureček,et al.  Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[11]  M. Simons,et al.  Central nervous system myelin: structure, synthesis and assembly. , 2011, Trends in cell biology.

[12]  J. Månsson,et al.  Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice , 2011, Lipids in Health and Disease.

[13]  J. Powers,et al.  Myelin lesions associated with lysosomal and peroxisomal disorders , 2010, Expert review of neurotherapeutics.

[14]  G. Comi,et al.  Characterization of new arylsulfatase A gene mutations reinforces genotype‐phenotype correlation in metachromatic leukodystrophy , 2009, Human mutation.

[15]  R. Schiffmann,et al.  Falsely elevated urinary Gb3 (globotriaosylceramide, CTH, GL3). , 2009, Molecular genetics and metabolism.

[16]  M. Eckhardt.  The Role and Metabolism of Sulfatide in the Nervous System , 2008, Molecular Neurobiology.

[17]  David W. Russell,et al.  LMSD: LIPID MAPS structure database , 2006, Nucleic Acids Res..

[18]  P. Taylor.  Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. , 2005, Clinical biochemistry.

[19]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[20]  S. Regis,et al.  Contribution of arylsulfatase A mutations located on the same allele to enzyme activity reduction and metachromatic leukodystrophy severity , 2002, Human Genetics.

[21]  P. Meikle,et al.  Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry. , 2001, Molecular genetics and metabolism.

[22]  J. Rip,et al.  A simple spectrophotometric enzyme assay with absolute specificity for arylsulfatase A. , 1998, Clinical biochemistry.

[23]  K. von Figura,et al.  Molecular basis of different forms of metachromatic leukodystrophy. , 1991, The New England journal of medicine.

[24]  K. von Figura,et al.  Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Fluharty,et al.  Pseudo arylsulfatase A deficiency: evidence for a structurally altered enzyme. , 1983, Biochemical and biophysical research communications.